Xiaoshuan Tongluo Tablets
Natural health product licensed in Canada
- Other names
- Astragali Radix Formula, Blood Detox Tablets, Collaterals Invigorating Tablets
- Licence holder
- 11741217 Canada Inc.
- NPN or DIN-HM
- 80134227
- Status
- Active licence
- Licence date
- 11 September 2024
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Salvia miltiorrhiza Source : Salvia miltiorrhiza - racine et rhizome Extract : Matériel brut sec Extraction ratio : 7.679:1 Dry plant equivalent : 215 mg | 28 mg | Not calculated |
| Styphnolobium japonicum Source : Styphnolobium japonicum - fleur Extract : Matériel brut sec Extraction ratio : 7.66:1 Dry plant equivalent : 72 mg | 9.4 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Talcum, Sucrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 6 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine. Used in Traditional Chinese Medicine (TCM) to activate blood, resolve stasis, warm and unblock the meridians. Used in Traditional Chinese Medicine for symptoms due to static blood obstructing the collaterals, manifested as fixed and stony expression, sluggish speech, cold and aching limbs; hyperlipidaemia with the symptoms described above.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80134227
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.